In 2017, your association surpassed major growth milestones; brought new resources to Pennsylvania's life sciences commu
2 0 1 7 L I F E
S C I E N C E S
P E N N S Y LVA N I A
ANNUAL REPORT
2 0 1 7 ANNUAL REPORT
C O N N E C T. A D V O C AT E . A D VA N C E . L I F E S C I E N C E S P E N N S Y L VA N I A W W W. L I F E S C I E N C E S PA . O R G
TA B L E O F C O N T E N T S LETTER TO MEMBERS
4
S T R AT E G I C P R I O R I T I E S
6
LIFE SCIENCES CENTER
7
E C O N O M I C I M PA C T R E P O R T
8
ADVOCACY 9 PROGRAMS 13 PA R T N E R S 1 9 MEMBERSHIP 20 BOARD OF DIRECTORS
25
GOVERNANCE COMMITTEES
26
SPONSORS 27
2
3
A LETTER TO OUR MEMBERS C O N N E C T. A D V O C AT E . A D VA N C E .
VISION
In 2017, your association surpassed major
membership. When we take a deeper look
an addition to Life Sciences PA’s Summit
were funded at the same level as the prior
growth milestones; brought new resources
into the make-up of our membership, we
Series, designed to help new entrepreneurs
fiscal year. The R & D Tax Credit was again
Pennsylvania is considered the most attractive
to Pennsylvania’s life sciences community by
see that there has been growth among all
learn the strategies and techniques used by
supported at $55 million.
location in the United States for establishing
way of innovative programming; achieved
sectors and in multiple regions throughout
experienced and successful entrepreneurs.
significant legislative successes at both the
the state of Pennsylvania.
state and federal levels; and furthered our
a rise of companies and organizations
mission of providing membership services
with fewer than 10 employees creating
and facilitating strategic connections by
businesses in Pennsylvania and joining our
expanding our offices in Wayne, PA to
membership.
create @LSPA – The Life Sciences Center,
and entrepreneurs speaks to the health…
the newest member benefit available to all
and fragility…of the life sciences industry.
a life sciences organization by life sciences leaders within the U.S. and by those outside the U.S. seeking to establish U.S. operations.
MISSION
Life Sciences PA members.
Life Sciences Pennsylvania’s mission is to
have experienced another year of making
ensure Pennsylvania is the United States hub
connections, advocating on behalf of the
for the life sciences by creating a business and public policy environment which fosters life sciences growth and success.
industry and advancing the life sciences in Pennsylvania.
We also saw a statewide and national
more programs targeted to specific sectors
policy approach to the opioid issue.
of and
our
membership,
lasting
facilitating
connections,
unique
continuing
to
represent our membership on the state and
events in 2017, including our Annual Dinner,
your association with the same number of
where 1,200 guests convened to celebrate
employees.
of our industry; the Spring Social, which has
nearly 300 life sciences executives came
our achievements in 2017, a snapshot of
together for a series of relaxing evenings
the successes of our membership, and the
to meet new colleagues and reconnect with
steps we’ve taken forward as a community.
those familiar; the Holiday Mixer, where a
record
200+
industry
professionals
gathered at the new Life Sciences Center for networking over cocktails and hors d’oeuvres;
and
Stadium
Advice
–
the
first-ever
from
the
Start-Up All
Stars,
We will continue to work closely with our national trade association partners and with our legislative champions.
20 17
We continue the progression of our strategic priorities to ensure a supportive climate in Pennsylvania to support company formation
the successes and outstanding achievements
pictures, and graphics – to share with you
associations in the United States in terms of
membership dues by executing and designing
than ever, all while continuing to operate
opportunity; our C-level Dinners, where
puts us among the top life sciences trade
drug pricing remains real in both capitals.
We held 32 educational and networking
This report offers us the chance – in words,
than 750 organizations in 2017, which
Life Sciences PA made the most of your
federal levels, and recruiting more members
been rated Life Sciences PA’s top networking
Life Sciences PA membership grew to more
4
The rise of small businesses
We’ve made
meaningful progress, by all measures, and
The threat posed by bad policy concerning
We also saw
In our advocacy efforts in Harrisburg and Washington, we met the challenges and threats head-on with many successes.
We
watched a new administration take shape in D.C. and saw approval of many longnegotiated issues.
and
retention
in
the
Commonwealth;
facilitate partnerships to advance company formation, innovation, job creation and success in the industry; and provide valued services for Association members. Together, we thank you for your continued
The Pennsylvania state budget remained burdened with structural debt and many more requests for limited funds. Fortunately, our allies in the Life Sciences Green House
support. CHRISTOPHER P. MOLINEAUX PRESIDENT & CEO
and Ben Franklin Technology Partners and our
state-supported
research
institutions
5
S T R AT E G I C P R I O R I T I E S
THE LIFE SCIENCES CENTER T o further our mission of providing membership services and facilitating strategic connections,
and
we have expanded our offices in Wayne, PA
industry,
to create @LSPA – The Life Sciences Center for
small companies, research institutions and
Pennsylvania. Our new, 8,600 square-foot Center
funding organizations to advance company
offers our members:
Facilitate
1
Ensure a supportive business and public policy climate in Pennsylvania to support company formation and retention in the
2
among
partnerships entrepreneurs,
between large
formation, innovation, job creation and
Commonwealth.
success in the industry.
• Networking and educational events • Happy hours • Meeting space • Center-wide internet service
3
Promote and support strategic engagement between
the
Pennsylvania
life
sciences
industry and key industry stakeholders.
4
Support efforts to position Pennsylvania as a top location for life sciences business and opportunity through select communication
• Q uiet, secluded rooms for phone calls, videoconferences or teleconferences • Conference and training rooms
initiatives. The Center is the newest member benefit available to all LSPA members.
5
Provide valued services and access to costefficient resources for Association members to make informed decisions and grow their businesses.
6
7
ADVOCACY SUCCESSES IN 2017
E C O N O M I C I M PA C T O F T H E L I F E S C I E N C E S I N D U S T R Y
I
n September, Life Sciences PA and KPMG released the 2017 Pennsylvania Life Sciences Impact Report, showcasing the significant role of the Pennsylvania life
sciences in leading national research and innovation, and driving the state economy.
peer states—California, Indiana, Massachusetts, Michigan, New Jersey, New York
T
and North Carolina. The peer states were selected based on their high concentration
In Washington, we worked closely with our national partners to secure affirmative votes for the
of life sciences activity relative to the national economy and their focus on research,
user fee legislation that must be renewed every five years and affects every sector of our industry.
development, and innovation.
President Trump signed the legislation into law in August. We also have advocated for important
The report compared Pennsylvania’s life sciences industry with that of designated
he advocacy efforts of Life Sciences Pennsylvania saw many notable successes in 2017 at the state and federal levels.
changes to the Affordable Care Act. The repeal of the Independent Payment Advisory Board was
Below is a summary of the contribution of the life sciences industry to the Pennsylvania
passed by the U.S. House of Representatives. We continued the work on our number one federal
economy. The report was presented during the Life Sciences Future conference.
legislative priority – the full repeal of the Medical Device Tax. We applaud the vote to reform our national tax system, which will allow many of our members to devote more resources to research
KEY FINDINGS*
and development. In recognizing the valuable contribution that the National Institutes of Health (NIH) play in basic scientific research, we are working with our congressional delegation in
LI F E S CIE NC E S I N PE N N S Y LVA N I A
ATTR AC TING CA P I TA L
Over the past five years, the life sciences industry experienced
Pennsylvania secured $147 million in venture capital funding in 2016,
gains in research, testing, and medical laboratories but a decline in
ranking 13th nationally and citing a need for investment moving forward.
pharmaceutical manufacturing, leading to uneven growth. The life
The
than half of the establishments comprised of fewer than 10 employees.
in
life
sciences
2016,
and
industry
indirectly
directly created
employed an
112,000
230,000
jobs
Technology Partners, they were restored to 2016 levels. The valuable Research & Development
expenditures.
The
Tax Credit remained at $55 million. In the prior fiscal year, more than 30 member companies
additional
through
In comparison to peer states, Pennsylvania had the highest 2016
industry generated a total state economic output of $88.5 billion.
National Science Foundation (NSF) funding rate, and the secondand
National
Institutes
of
Health
(NIH)
business
purchases
and
household
at the Life Sciences Greenhouses remained intact. After a brief threatened cut to the Ben Franklin
people
R E S E ARCH E X C E L L E N C E
NSF
We saw slow, but positive work on the state budget in Harrisburg, PA. The funding for our allies
EC ONOMIC CONTRI BUTI ON
sciences industry continues to be small business oriented, with more
highest
securing more funding for this important agency.
were awarded $13.3 million in tax credits.
COMMONWEALTH SUPPORT
funding
life
Threats exist in this environment in both capitals. For example, an ill-advised drug pricing bill was
sciences industry in the form of a dedicated agency, incentive
voted out of a state senate committee in December. We are working with our member companies
The
per capita. In the past five years, Pennsylvania was among the top five states in patent contributions, receiving 4,317 patents.
Commonwealth
of
Pennsylvania
offers
support
to
the
programs, and specific appropriations for life sciences programs.
to defeat this legislation that would expose proprietary financial information to competitors.
A C ADE MI C C ON T R I B U T I ON Pennsylvania universities conferred 578 doctorate degrees, ranking
Visit www.lifesciencespa.org/advance to view the full report.
4th highest in the nation during 2015. The state had seven of the top 100
*Source: Pennsylvania Life Sciences Industry. Report prepared by KPMG.
universities, including two in the top 100 Biological Sciences Program.
JAN 8
members that their voices are the ones needed in these capitals.
September 2017.
2017 MEMBER MILESTONES Synergy Pharmaceuticals receives FDA approval of Trulance for chronic idiopathic constipation
While we remain vigilant and active in Harrisburg and Washington, D.C., we remind our
FDA approves Egalet’s tamper-resistant chronic pain medicine – Arymo ER C-II
FEB Amgen, Inc. receives FDA approval of Parsabiv for secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis
AstraZeneca receives FDA approval of Qtern for inadequately controlled type 2 diabetes
9
S TAT E P O L I C Y C O M M I T T E E
FEDERAL POLICY COMMITTEE
TIM SULLIVAN, GSK (CHAIR)
AMY REDL, SANOFI (CHAIR)
BRYAN LEWIS, KCAN/ACKC
JEREMY ALLEN, SPARK
JOE MCGOWAN, NOVARTIS
BILL ANDRESEN, PENN
GREG MONTANARO, DREXEL
GREG ARONIN, PARAGON
CARA MOON, EGALET
COURTNEY LEE ASHLEY, MERCK
RITA NORTON, AMERISOURCEBERGEN
DANIEL AMBURN, UCB DOM ARGENTO, MERCK MARTHA AUSTER, VERTEX CHRIS BECK, PENN MEDICINE
KATHRYN LAVRIHA, SANOFI WENDY LAZARUS, PFIZER CHARLES LEITGELB, BAYER TIMOTHY LYDEN, ELI LILLY
SAUL BEHAR, SCIENCE CENTER
TIMOTHY P. MCNULTY, CMU
BRENDAN BENNER, MDMA
CARA MOON, EGALET
MEL BILLINGSLEY, LSGPA
PATRICK NORTON, PENN MEDICINE
JULIE COHEN, JOHNSON & JOHNSON
MARK O’ROURKE, TAKEDA
MICHELLE CONSALVO, SHIRE
JOY RUSSELL, GENENTECH
LINDA DAVIS, JANSSEN BIOTECH
MATT RUTH, ALMAC
PATRICK DENTINGER, ABSORPTION SYSTEMS JULIE EDDY, AMERISOURCE BERGEN NEELY FRYE, NOVARTIS VITO GALLO, LEHIGH UNIVERSITY ETHAN HASBROUCK, BMS GABRIEL HOLDSMAN, BTG
ANDY SANDUSKY, ABBVIE BARBARA SCHILBERG, BIOADVANCE DAVI D SMITH, PEPPER HAMILTON
PAULA BURG, PFIZER CARLA CARTWRI GHT, JOHNSON & JOHNSON
JED PERRY, SHIRE JESSE PRICE, ELI LILLY
PATRICK COLLINS, CSL BEHRING
MATTHEW RUTH, ALMAC
TIM FENTON, THERMO FISHER SCIENTIFIC
STEPHEN SCANGO, ABBVIE
TONY GIBSON, PITT
JENNIFER EVANS STACEY, WISTAR
PETER GROLLMAN, CHOP
DEBBIE TEKAVEC, CMU
KRISTIN DINI HERNANDEZ, TEMPLE
PHIL THEVENET, GSK
GABE HOLDSMAN, BTG CHRIS KOVOLSKI, VILLANOVA
LIFE SCIENCES CAUCUS CO–CHAIRS O U R L E G I S L AT I V E C H A M P I O N S I N H A R R I S B U R G
MARY LEE WATTS, AACR
S EN. AND Y D I NNI M AN
S EN. B O B M ENS C H
(D-CHESTER)
(R-BERKS, BUCKS, MONTGOMERY)
R E P. TIM BR IG G S (D-MONTGOMERY)
R E P. WA R R E N K A M PF
R E P. M A R K LON G IE TTI
(R-CHESTER)
(D-MERCER)
R E P. SCOTT PE TR I (R-BUCKS)
2 0 1 7 P U B L I C A F FA I R S S E R I E S S P O N S O R S
PAUL WILLIAMS, BMS
JENNIFER EVANS STACEY, WISTAR DEBRA STARK, BIR KARLA WHITE, CSL BEHRING DAVI D WILSON, DREXEL
2017 MEMBER MILESTONES
MAR
EMD Serono/Pfizer receives FDA approval of Bavencio for Merkel cell carcinoma
10
Genentech receives FDA approval of Ocrevus for multiple sclerosis
APR Novartis receives FDA approval of Kisqali for breast cancer
Harrisburg University opens a new biotechnology master’s program
Paratek Pharmaceuticals expands operations in King of Prussia, PA
Radius Health receives FDA approval of Tymlos for postmenopausal women with osteoporosis at high risk for fracture
Teva Pharmaceuticals receives FDA approval of Austedo for chorea associated with Huntington’s disease and tardive dyskinesia
Novartis receives FDA approval of Rydapt for FLT3 positive acute myeloid leukemia and mastocytosis
11
PROGRAMS F
U.S CONGRESSIONAL ENGAGEMENT
rom our Signature events to the smallest Special Interest programs, Life Sciences Pennsylvania produces a variety of programs each
RARE DISEASE CAUCUS
W
year. LSPA programs provide attendees opportunities to connect and interact with colleagues and industry leaders while staying
ith potential patient pools so small, there is often a personal story behind these companies’ foundings. As we continue to learn more about rare diseases, we have come into contact with a host of brave and passionate people — individuals committed to
supporting research and development of new treatments and therapies for patients dealing with rare disease each and every day. This
abreast of the latest developments and hot topics in life sciences. During the 32 programs held in 2017, more than 4,000 individual attendees heard from world-renowned speakers, breakthrough researchers and investment pioneers. Life Sciences Pennsylvania continues to provide a forum for the life sciences community to stay connected and continue growing.
bi-partisan and bi-cameral caucus works to educate other legislators on the needs and challenges of the 1.2 million Pennsylvanians who have a rare disease. We have seen quick action in Harrisburg as State Representative Marcy Toepel’s bill creating a Rare Disease Advisory Council was signed by the Governor in the summer.
R E P R E S E N TAT I V E S DUANE MILNE, CHESTER
LYNDA CULVER, NORTHUMBERLAND, SNYDER
THOMAS MURT, MONTGOMERY, PHILADELPHIA
JOHN GALLOWAY, BUCKS
KRISTIN PHILLIPS-HILL, YORK
MARK LONGIETTI, MERCER STEPHEN MCCARTER, MONTGOMERY
CAMERA BARTOLOTTA, BEAVER, GREENE, WASHINGTON LISA BOSCOLA, LEHIGH, NORTHAMPTON
CURTIS SONNEY, ERIE
MICHELLE BROOKS, CRAWFORD, ERIE, MERCER, WARREN
MARCY TOEPEL, MONTGOMERY
JAKE CORMAN, CENTRE, JUNIATA, MIFFLIN
JUDY WARD, BLAIR
JAY COSTA, ALLEGHENY ANDY DINNIMAN, CHESTER PATRICK STEFANO, FAYETTE, SOMERSET, WESTMORELAND ROBERT TOMLINSON, BUCKS GENE YAW, BRADFORD, SULLIVAN, LYCOMING
2017 MEMBER MILESTONES
MAY
Sanofi receives FDA approval of Kevzara for active rheumatoid arthritis
12
FUTURE IN SEPTEMBER (SEE P. 17 FOR DETAILS)
S E N AT O R S
PAUL COSTA, ALLEGHENY
WARREN KAMPF, CHESTER
CELLICON VALLEY PANEL FROM LIFE SCIENCES
AstraZeneca receives FDA approval of Imfinzi for advanced or metastatic urothelial carcinoma
JUN Inovio Pharmaceuticals announces strides toward a breakthrough HIV vaccine
CSL Behring receives FDA approval of Haegarda for routine prophylaxis to prevent hereditary angioedema attacks
Pittsburgh Life Sciences Greenhouse and Helomics partner to launch a diagnostics and precision medicine incubator
Neuronetics, Inc. receives $15M in funding for Neurostar
Fibrocell announces development of gene therapy with transformative potential for patients with recessive dystrophic epidermolysis bullosa 13
ANNUAL DINNER I
n Pennsylvania, our industry is defined by individuals and leaders who work tirelessly toward one overriding goal: helping patients around the world by addressing unmet medical needs. Through this unwavering dedication, Pennsylvania continues to be a global leader across the life sciences
industry. Each year, more than 1,200 life science professionals gather for the Annual Dinner to celebrate the successes of the prior year and to honor visionary leaders of the past whose legacies guide our industry in Pennsylvania.
2017 PROGRAM OVERVIEW
32
2 0 1 7 AWA R D R E C I P I E N T S
88
PROGRAMS
SPEAKERS
1, 1 2 1
4, 150
C O M PA N I E S REPRESENTED
AT T E N D E E S
CLARKSTON CONSULTING SCHOLARSHIP ERIC MCELHINNY, UNIVERSITY OF PITTSBURGH
PATIENT IMPACT AWARD JEFFERSON HEALTH SYSTEM
DEAL OF THE YEAR AWARD ALLERGAN ACQUISITION OF VITAE PHARMACEUTICALS
PRESIDENT’S SERVICE AWARD CHARLES R. HUNTINGTON, JR., SENIOR VICE PRESIDENTINVESTMENT OFFICER, THE HUNTINGTON/KRAUS FINANCIAL GROUP, WELLS FARGO
EMERGING COMPANY OF THE YEAR AWARD GENOMIND FEDERAL OFFICIAL OF THE YEAR AWARD CONGRESSMAN TIM MURPHY (R-18), U.S. HOUSE OF REPRESENTATIVES
SCIENTIFIC ACHIEVEMENT AWARD JULIUS YOUNGNER, SC.D., AMERICAN DISTINGUISHED SERVICE PROFESSOR EMERITUS, UNIVERSITY OF PITTSBURGH’S SCHOOL OF MEDICINE
FRANK BALDINO BIOSCIENCES CEO OF THE YEAR AWARD BOB RADIE, PRESIDENT & CEO, EGALET CORPORATION
STATE OFFICIAL OF THE YEAR AWARD SENATOR BOB MENSCH (R-24), PENNSYLVANIA STATE SENATE
HUBERT J.P. SCHOEMAKER LEADERSHIP AWARD M. STEPHEN HEILMAN, M.D., PRESIDENT, VASCOR, INC.
2017 MEMBER MILESTONES
JUL
1,178 clinical trials active in Pennsylvania
14
Janssen receives FDA approval of Tremfya for moderate-to-severe plaque psoriasis
OraSure Technologies receives WHO prequalification of OraQuick HIV Self-Test
Complexa raises $62M in series C financing to test CXA-10 in two orphan drug disease proof of concept trials
VenatoRx receives $9.4M from CARB-X to develop a new class of antibiotic to combat multi-drug resistant bacteria
Cutanea releases new mobile app for acne patients – Facing Forward
15
SUMMIT SERIES The Life Sciences Pennsylvania Summit Series is a collection of high-quality programs that are uniquely designed for and marketed to a
L
specific section of the LSPA membership. The Summits feature prominent industry speakers highlighting timely content, while providing numerous opportunities for strategic connections.
ife Sciences Future was developed with Pennsylvania’s diverse life sciences industry in mind – pharma, biotech, medical device and diagnostics, healthcare IT, contract
research organizations, academic research institutions, and the investment community.
Medtech + Digital Health Summit July 12, 2017 The Wistar Institute Philadelphia, PA
LSPA’s first MedTech + Digital Health Summit was a half-day program designed specifically for senior leaders, regulatory and quality experts, entrepreneurs, and business development executives from MedTech + Digital Health organizations in PA and beyond. The Summit featured various panel discussions focused on topics like innovation and funding, strategic priorities of the FDA, digital health analytics, and CMS reimbursement.
The agenda is driven by Life Sciences Pennsylvania members to ensure the content is relevant, engaging and thought-provoking.
M A J O R K E Y N O T E S & PA N E L I S T S OPENING KEYNOTE
Supply Chain Summit October 25, 2017 The Desmond Hotel Malvern Malvern, PA
Attendees at the LSPA Supply Chain Summit learned the newest strategies for handling life sciences industry supply chain needs. The event covered the state of global transportation, virtual supply chain management, product and serialization data, and good supply practices. Featured presenters included Paul Testa, Group Vice President at Shire, and Michael Araten, President and CEO of K’NEX BRANDS.
Jonathan Epstein, M.D., Executive Vice Dean and CSO, University of Pennsylvania, Perelman School of Medicine
Advice from the All Stars November 14, 2017 @LSPA - The Life Sciences Center Wayne, PA
CRO & CMO Summit November 17, 2017 West Pharmaceuticals Services, Inc.
Nearly 100 attendees participated in the first ever StartUp Stadium – Advice from the All Stars, an event designed to provide new entrepreneurs with strategies for successful pitching and presentations, in preparation for the JP Morgan Healthcare Conference and other investor conferences. The event showcased the most promising and innovative emerging companies in Pennsylvania, and created opportunities to meet with experienced legal and financial advisors, and other successful entrepreneurs from the life sciences industry. The CRO & CMO Summit was a half-day program designed specifically for those planning and conducting clinical trials, and those seeking advice on how to effectively partner with companies within the life sciences industry.
Dario Altieri, M.D., President and CEO, The Wistar Institute; Director, The Wistar Institute Cancer Center; Robert and Penny Fox Distinguished Professor
FROM THE HEART OF THE CELLICON VALLEY Adrian (Ad) Rawcliffe, CFO, Adaptimmune Jeff Marrazzo, CEO, Spark Therapeutics
Jessica Imrie, Head of Strategy and Operations for Cell and Gene Therapy within Rare Diseases, GlaxoSmithKline Moderator: Ali Gorman, R.N., Health and Medical Reporter, 6ABC Action News PATIENT SPOTLIGHT Montel Williams, Investor and Patient Advocate Phillippe Deschamps, President & CEO, Helius Medical Technologies
19 C O M PA N Y P R E S E N TAT I O N S
319
50 SPEAKERS + PA N E L I S T S
O R G A N I Z AT I O N S
Felix Hsu, Senior Vice President, Head of US Business Unit, WuXi AppTec
Jeri Lake, Patient
Exton, PA
703
POSTER P R E S E N TAT I O N S
T O TA L AT T E N D E E S
FIRESIDE CHAT
Moderator: Adam Taicher, Partner, Navigate Start-Up Stadium –
36
12
12 REVERSE PITCHES
S TAT E S R E P R E S E N T E D + WA S H I N G T O N , D . C
24 RESEARCH INSTITUTIONS
2017 MEMBER MILESTONES
AUG
AbbVie receives FDA approval of Mavyret for treatment of chronic HCV genotype 1,2,3,4,5 or 6
16
Jazz Pharma receives FDA approval of Vyxeos for treatment of newly-diagnosed therapy-related AML or AML with myelodysplasiarelated changes
Pfizer receives FDA approval of Besponsa for treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia
Helius Medical Technologies opens a new corporate facility in Newtown, PA
Absorption System opens CGMPcompliant testing facility for gene and cell therapy products
FDA approves first-ever T-cell cancer treatment—Kymriah— pioneered at CHOP and Penn, commercialized by Novartis
17
EXECUTIVE DINNERS
PA R T N E R S
Life Sciences Pennsylvania hosts C-Level dinners throughout the year, lending an exclusive opportunity to those serving in the capacity of Chief Executive Officer, Chief Scientific Officer, Chief Medical Officer, Chief Financial Officer, or head of R&D at a Life Sciences PA core member company, to network with their peers.
I N T E R N AT I O N A L PA R T N E R S ASSOBIOTEC ITALIA
Chief Scientific Officer Dinner July 20, 2017 St. Davids Golf Course Wayne, PA
Chief Financial Officer Dinner November 7, 2017 St. Davids Golf Course Wayne, PA
Chief Executive Officer Dinner November 28, 2017 Merion Golf Club Ardmore, PA
At the 2017 Chief Scientific Officer Dinner, Life Sciences PA members joined together for a relaxing evening to meet and reconnect with their colleagues, and hear a keynote presentation from guest speaker, Dr. David H. Ledbetter, Executive Vice President and Chief Scientific Officer, Geisinger. Dr. Ledbetter discussed Geisinger’s MyCode Community Health Initiative, a precision medicine project that involves enrolling patients at Geisinger locations in Pennsylvania and beyond, to store blood and other samples for use in research—particularly genetic research—by Geisinger and its collaborators.
INDO-US SCIENCE & TECHNOLOGY FORUM
LITHUANIAN BIOTECHNOLOGY ASSOCIATION
December 6, 2017 @LSPA - The Life
ONE NUCLEUS TAIWAN BIO INDUSTRY ORGANIZATION
N AT I O N A L PA R T N E R S
This event, offered to those serving in the capacity of Chief Financial Officer, Chief Executive Officer, and/or VP of finance, featured a night of networking, meeting new colleagues, and a discussion with guest speaker, Ketan Patel, M.D., Partner, F-Prime Capital Partners. Dr. Patel discussed recent investment and growth within the life sciences industry, the investment climate in today’s industry, and the nuances in investment culture between the Boston, San Francisco and Philadelphia regions.
Keynote speaker, Madeline Bell, President and CEO of Children’s Hospital of Philadelphia (CHOP), shared her insights and experiences in the life sciences industry during the 2017 Chief Executive Officer Dinner. She spoke to upcoming technologies at CHOP, the importance of strategic partnerships to CHOP’s future, and the ecosystem at CHOP that allows them to grow in the life sciences industry. The evening provided an opportunity to meet with new colleagues and network with other members.
R E G I O N A L PA R T N E R S
H O L I D AY N E T W O R K I N G E V E N T Holiday Mixer
KARNATAKA BIOTECHNOLOGY AND INFORMATION TECHNOLOGY SERVICES
ALLEGHENY CONFERENCE ON COMMUNITY DEVELOPMENT
GREATER PHILADELPHIA ALLIANCE FOR CAPITAL AND TECHNOLOGIES
PHILADELPHIA CONVENTION AND VISITORS BUREAU
BEN FRANKLIN TECHNOLOGY PARTNERS OF CENTRAL AND NORTHERN PENNSYLVANIA
HEALTHCARE INSTITUTE OF NEW JERSEY
PITTSBURGH LIFE SCIENCES GREENHOUSE
HERSHEY CENTER FOR APPLIED RESEARCH
PITTSBURGH TECHNOLOGY COUNCIL
BEN FRANKLIN TECHNOLOGY PARTNERS OF NORTHEASTERN PENNSYLVANIA
INNOVATION WORKS
SELECT GREATER PHILADELPHIA
LEHIGH VALLEY ECONOMIC DEVELOPMENT COUNCIL
THE CHAMBER OF COMMERCE FOR GREATER PHILADELPHIA
BIOADVANCE
LIFE SCIENCES GREENHOUSE OF CENTRAL PENNSYLVANIA
THE MAIN LINE CHAMBER OF COMMERCE
CHESTER COUNTY CHAMBER OF BUSINESS & INDUSTRY
NEW JERSEY BIO NEW JERSEY TECHNOLOGY COUNCIL
VALLEY FORGE CONVENTION AND TOURISM BOARD
PENNSYLVANIA BIOTECHNOLOGY CENTER OF BUCKS COUNTY
WORLD TRADE CENTER OF GREATER PHILADELPHIA
BEN FRANKLIN TECHNOLOGY PARTNERS OF SOUTHEASTERN PENNSYLVANIA
Before the holidays, Life Sciences PA had a chance to connect with the Board of Directors and new members in a festive setting during its annual Holiday Mixer. The informal mixer brought together LSPA members over cocktails and hors d’oeuvres.
Sciences Center
CHESTER COUNTY ECONOMIC DEVELOPMENT COUNCIL
Wayne, PA
DELAWARE BIO
UNIVERSITY CITY SCIENCE CENTER
2017 MEMBER MILESTONES
SEP
Bayer granted accelerates FDA approval on Aliqopa for treatment of follicular lymphoma
18
Genentech receives FDA approval of Actemra for CAR T-cell induced cytokine release syndrome
GlaxoSmithKline and Adaptimmune partner to advance and commercialize T-cell therapy program
Temple University and University of Pittsburgh selected by NIH as two of 11 clinical hubs nationwide
National Lacrosse League and Egalet Corporation announce education partnership to promote non-narcotic pain option and responsible pain management
CSL Behring presents Penn State University with a $4.92M gift to help transform biotech education and research
19
WELCOME 2017 NEW MEMBERS
MEMBERSHIP
I
n 2017, Life Sciences Pennsylvania experienced a recordbreaking year for membership growth, ending the year with
755 member organizations representing all sectors of the life sciences: biotech, pharma, devices, diagnostics, research,
755 MEMBER C O M PA N I E S
funding, digital health, contract research organizations, patient advocacy groups, and service providers. A deeper look into the membership composition shows growth among all sectors and in multiple regions throughout the state, as well as an increase in the number of organizations with fewer than 10 employees—a direct testament to both the vibrancy but fragility of the life sciences community. The increasing size and diversity of our membership puts Life Sciences PA among
135 NEW MEMBERS IN 2017
the top life sciences trade associations in the United States. While our membership continues to evolve, what has not changed is our commitment to creating a business and policy environment which fosters life sciences growth and success. This expanded network provides even greater opportunity to facilitate strategic connections among members and to advocate for effective public policy. Together, Life Sciences PA seeks to create an environment to ensure the Commonwealth is considered the most attractive location in the United States
1,393
MEMBERS CONNECTED I N L S PA P R I VAT E L I N K E D I N G R O U P
for establishing a life sciences organization.
2017 MEMBER MILESTONES
OCT 20
GlaxoSmithKline receives FDA approval of Shingrix for herpes zoster (shingles)
Pittsburgh Life Sciences Greenhouse awarded a grant for health information technology programs
Inovio Pharmaceuticals, Wistar Institute, the University of Penn, and GeneOne Life Sciences team up to tackle Zika
Harmony Biosciences raises $270M and acquires exclusive US rights to develop and market pitolisant, a narcolepsy drug from Bioproject
Strongbridge BioPharma raises $23.4M. Proceeds will support development and expansion of several experimental and approved treatments
3FX ACADEMY OF NOTRE DAME DE NAMUR ACCURA TECHTONIQ LLC A D VA N C E D R P O ALEXANDERWERK, INC. ALLERGAN, INC. A M Y L O I D O S I S F O U N D AT I O N APO TECHNOLOGIES, INC. ARCWEB TECHNOLOGIES ARIEL PRECISION MEDICINE AZER SCIENTIFIC AZZUR GROUP LLC B A K E R T I L LY BEACON HILL PHARMA BLINK CONSULTING B O TA N I X P H A R M A C E U T I C A L S L T D . BOUNDARY MEDICAL B R I D G E I N N O VAT I O N S B U C H A N A N P U B L I C R E L AT I O N S C A L I B E R A S S O C I AT E S CANCER GENETICS, INC. CAPGENIC ADVISORS CAREER CONCEPTS, INC. DBA CCI CONSULTING CAREFORM CARMA THERAPEUTICS LLC CBM GROUP CENERO CENTER CITY FILM & VIDEO CFGI CIRCADIANCE CIVI BIOPHARMA, INC. CONRAD O’BRIEN, PC CONSEGNA PHARMA COOK MYOSITE, INC. COOLEY LLP C O U R A G E G R O W T H PA R T N E R S C U R I N G R E T I N A L B L I N D N E S S F O U N D AT I O N DECHERT LLP DREAMIT VENTURES E . M . M . A . I N T E R N AT I O N A L C O N S U L T I N G G R O U P EDSPIRE ELEVEN BIOTHERAPEUTICS, INC. EXCALIVIR, INC. E Y WA P H A R M A FIVE RIVERS RX
Aevi Genomic Medicine announces a $28M private stock placement led by CHOP. The CHOP Foundation will provide an additional $5M in equity financing
F M C O S T C O N TA I N M E N T L L C F R E S H S TA R T C A R E E R S FRIEDMAN LLP FRONTIDA BIOPHARM, INC. FULTON BANK GEMINI ADVISORS GO2 HARMONY BIOSCIENCES HCP CONCIERGE, LLC H E A L T H C A R E R O YA L T Y PA R T N E R S HELIUS MEDICAL TECHNOLOGIES HUMOTECH IMMUNOMET THERAPEUTICS, INC. I M VA X I N D U S T R Y S TA N D A R D R E S E A R C H I N T R AV E N T M E D I C A L PA R T N E R S , L P J.N. SOLUTIONS LLC JPG HEALTHCARE LLC L . E . A . F. P H A R M A C E U T I C A L S L L C L AW L E Y LIPELLA PHARMACEUTICALS, INC. LOCKTON, CO. L U M I S C O R P. L Y O P H I L I Z AT I O N T E C H N O L O G Y, I N C . MARKITECTS, INC. MASTERCONTROL, INC. MAZARS USA, INC. MEDNET SOLUTIONS MEKHOS HEALTH LLC MIKAN GROUP MJ WOODDELL LLC MOBILION SYSTEMS M V M L I F E S C I E N C E PA R T N E R S L L P NAMSA N AT I O N A L ATA X I A F O U N D AT I O N N AT I O N A L O S T E O P O R O S I S F O U N D AT I O N N E O V I TA B I O P H A R M N E P H C U R E K I D N E Y I N T E R N AT I O N A L F O U N D AT I O N NEURORX, INC. NMS LABS NOBLE LIFE SCIENCES, INC. ONCORA MEDICAL, INC. ONSPIRA THERAPEUTICS, INC. OPTINOSE OPTUM LIFE SCIENCES O R T H O - TA G
Optinose closes $138M stock offering. Money raised will support launch and development efforts for Xhance for treatment of nasal polyps in adults
PA B R E A S T C A N C E R C O A L I T I O N PENDULUM CLINICAL DEVELOPMENT C O N S U L TA N T S , L L C PHARMALEX DEVELOPMENT SERVICES, LLC P R O L I FA G E N L L C PSIOXUS THERAPEUTICS PUBLICIS HEALTH PULMONESCENCE DIAGNOSTICS Q U A N T I TAT I V E R A D I O L O G Y S O L U T I O N S QUANTUS, INC. QUARTESIAN QUEBEC TRADE OFFICE IN PHILADELPHIA RECENSA THERAPEUTICS R E C T O R C O M M U N I C AT I O N S , I N C . R E N E R VA , L L C RUBITECTION SCIENCE HISTORY INSTITUTE SD MEDED, INC. S FA T H E R A P E U T I C S SICK CELLS SIMON’S FUND S L V E R N I C K C O M M U N I C AT I O N S SMARTCPR SMITHWISE SPRINGER LEADERSHIP STYERGROUP SUAZIO CONSULTING SUNOVION PHARMACEUTICALS, INC. TA K E D A P H A R M A C E U T I C A L S U S A , I N C . TA L E E B I O T H E B A N D I S H G R O U P, L L C T H E R A P E U T I C A R T I C U L AT I O N S L L C THERMAQUIL, INC. TMUNITY THERAPEUTICS, INC. T R O V I TA H E A L T H S C I E N C E TUNNELL CONSULTING VA L L E Y F O R G E T O U R I S M & C O N V E N T I O N B O A R D V I L L A N O VA U N I V E R S I T Y V I R PA X P H A R M A C E U T I C A L S , I N C . W E S T E R N PA C H A P T E R , N AT I O N A L H E M O P H I L I A F O U N D AT I O N W H C & A S S O C I AT E S WITHUMSMITH+BROWN WIZSOLUTION LLC WUXI APPTEC, INC. YOUR GENERAL COUNSEL LLC
Arbutus Biopharma corporation & Gritstone Oncology sign licensing deal for personalized cancer immunotherapies
US FDA approves new easy-to-use, once-weekly BYDUREON BCISE injectable medicine for patients with type 2 diabetes
21
DIAMOND MEMBERS
MEMBERSHIP GROWTH OVER TIME
BioPharm Devices
BioPharm Insight
MEMBERSHIP 800 600
604
651
674
755
716
547
504 432
400 346
308
378
LEADERSHIP MEMBERS
200
2007
2008
2009
2010
2011
2012
MEMBERSHIP BY SECTOR
2013
2014
2015
2017
C O R E & A S S O C I AT E M E M B E R S
6%
39%
40%
755
11%
2016
2017
20 1 7
60%
40%
biotechnology or pharmaceutical research and development, drug discovery, medical device
3%
2%
development, and contract 15% 4%
5%
14%
7%
L I BERTY P R O P ERTY TR U ST
BALLAR D SPAHR LLP
DU A NE MO R R I S L L P
L I L LY U SA , L L C
BR I STOL-MYE R S SQU I BB C OMPANY
E R NST & Y O U NG , L L P
MO R G A N, L EW I S & BO CKI U S L L P
C E LE R I ON, I NC .
F I SH ER SCI ENTI FI C
MO R P HO TEK, I NC.
C ONNE R STR ONG & BU C KE LE W
I R OK O P HA R MA CEU TI CA L S, L L C
P ECO , A N EX EL O N CO MPA NY
KPMG L L P
P EP P ER HA MI LTO N L L P
TA KED A P HA R MA CEU TI CA L S, U SA , I NC. TEL EFL EX I NCO R P O R ATED THE SA R I A N G R O U P AT HI G HTO W ER W U X I A P P TEC, I NC.
to the life sciences industry. Core: Organizations involved in
12%
DSM BI O MED I CA L
consulting and business services
13%
716
ALMAC GR OU P
Associate: Businesses providing
7%
14%
2016
research organizations involved
5%
in preclinical research.
2%
1%
BIO T ECH 1 5 %
B I OT E CH 14%
AS S O C IAT E 3 0 2 COR E 4 5 3
S E RV I C E ORGANI Z ATI ON 39%
FUNDING 2 %
S E R V I CE OR GAN I ZAT I ON 40%
F UN DI N G 3%
C RO 7%
MEDICA L DEVICE 1 2 %
C R O 5%
M E DI CAL DE V I CE 11%
PAT IEN T AD V OC AC Y 4%
PHA RMA 1 4 %
PAT I E N T ADV OCACY 5%
PHAR M A 13%
D IG ITAL H EALTH 1%
RESEA RCH / UNIVERSIT Y 6 %
D I GI TAL HE ALT H 2%
R E S E AR CH / UN I V E R S I T Y 7%
MEDICAL DEVICE & DIAGNOSTICS COMMITTEE BR U C E SHOOK, I NTAC T VASC U LAR (C HAI R ) DAVI D ANDE R SON, ORTE Q NE I L C AMPBE LL, MOSAI GE N ADAM DAKI N, PLE XU S
TOM HESS, G ENO MI ND GAB E HO L D SMA N, BTG
CHR I STI A N MA ND ER S, P R O METHEA N L I FE SCI ENCES
LI AM KEL LY, TEL EFL EX
CHR I STO P HER MO L I NEA U X , L I FE SCI ENCES P ENNSY LVA NI A
MAR C MA L A ND R O , I NNO VATI O N I NSTI TU TE
JO HN SCHU EL ER , FU JI R EBI O
R O N SPA I R , O R A SU R E ER I C TEU TSCH, D SM BI O MED I CA L A L A N W EST, P I TTSBU R G H L I FE SCI ENCES G R EEN HO U SE
D I G I TA L H E A L T H C O M M I T T E E MU KHTAR AHME D (C HAI R ), BI OC LI NI C A
JASO N FR ED ER I CK, ER NST & YOUNG
MAR I A F OR E R O, R I DGE TOP HE ALTH
DAV I D L I ND SAY, O NCO R A MED I CA L
FR A NK MI NEL L A , PA I NQ X O O D AY E SHU KL A , HV H PATI ENT P R ECI SI O N A NA LY TI CS
THO MA S W O L SKI , THE W EBB L AW FI R M
2017 MEMBER MILESTONES
NOV
Genentech, Inc. receives FDA approval of Hemlibra for prevention or reduction of bleeding episodes in patients with hemophilia A
22
Merck receives FDA approval of Prevymis for cytomegalovirus following allogenic hematopoietic stem cell transplant
Genisphere LLC raises $7M to advance its 3DNA nanotechnology platform designed to improve targeted drug delivery
Brandywine & Drexel break ground on Schuylkill Yards – a $3.5B project
Onconova Therapeutics raises $1.4M to focus on late-stage clinical testing of lead drug candidate, IV Rigosertib, for myelodysplastic syndromes
FDA approves Genentech’s HEMLIBRA (emicizumabkxwh) for hemophilia A with inhibitors
Recro Pharma announces $100M financing deal managed by Athyrium Capital management. Funds will support a milestone for IV meloxicam for moderate-to-severe pain
CIC partners with University City Science Center & Venture Café in Philadelphia Innovation Center
23
S AV I N G M I L L I O N S F O R M E M B E R S
2017 BOARD OF DIRECTORS
T
ARMANDO ANIDO Chairman of the Board & Chief Executive Officer Zynerba Pharmaceuticals
he Life Sciences Pennsylvania SAVE Program (Service, Access, Value and Ease) is a powerful group purchasing program offering discounts on products and services to LSPA members. This program enables members to grow and expand their current operations, while saving capital and
ERIN BRUBAKER Vice President, R&D Strategy Development GlaxoSmithKline Pharmaceuticals
resources. In 2017, our members saved more than $8.4 million by utilizing our member services program.
BioPharm Devices
M E M B E R S AV I N G S , GROUP PURCHASING
BioPharm Insight
CHRISTOPHER BURNS, PH.D. President & Chief Scientific Officer VenatoRx Pharmaceuticals CHRISTOPHER CASHMAN President & Chief Executive Officer Marinus Pharmaceuticals
10
$8.4M
BRIAN DOERNER Partner Ballard Spahr LLP
8
$6.5M Savings (in millions)
6
the sarian group
JAMES DATIN President & Chief Executive Officer BioAgilytix
MATTHEW GANTZ Chief Executive Officer OxThera
$5.2M
MAXINE GOWEN, PH.D. President & Chief Executive Officer Travena, Inc.
$4.5M
NINA GUSSACK Partner Pepper Hamilton LLP
4
BRIAN HALAK, PH.D. Partner Domain Associates GABRIEL HOLDSMAN General Counsel US, Senior Vice President, Legal Operation BTG International Inc.
2
0
2014
2015
2016
2017
JOHN HUBBARD, PH.D., FCP President & Chief Executive Officer BioClinica, Inc.
JOSEPH LA BARGE Head of Business Administration & General Counsel Spark Therapeutics, Inc.
JULIAN RITCHEY US Head Vaccine Public Affairs and Advocacy Sanofi Pasteur
MAHMOOD LADHA Head of US Business Operations AstraZeneca Pharmaceuticals
JOHN RYAN President & Chief Executive Officer Unilife Corporation
DAVID LEDBETTER, PH.D. FACMG Executive Vice President & Chief Scientific Officer Geisinger Health System
KATHLEEN SHAY Partner Duane Morris LLP
TERRI LEE TAYLOR Vice President, State Government Affairs & Policy Merck & Co., Inc. JEFFREY LIBSON Partner Cooley, LLP MARC MALANDRO, PH.D., CLP, RTTP Vice President of Operations, Science Chan Zuckerberg Initiative CHRISTIAN MANDERS Chief Operating Officer Promethean LifeSciences VINCENT MILANO Chief Executive Officer Idera Pharmaceuticals, Inc. CHRISTOPHER MOLINEAUX President & Chief Executive Officer Life Sciences Pennsylvania RITA NORTON Senior Vice President Government Affairs & Public Policy AmerisourceBergen Corporation ROBERT RADIE President & Chief Executive Officer Egalet, Inc.
ERIC TEUTSCH President DSM Biomedical STEPHEN TULLMAN Managing Partner NeXeption NEAL WALKER, D.O. President & Chief Executive Officer Aclaris Therapeutics
BRUCE SHOOK President & Chief Executive Officer Intact Vascular, Inc.
BRYAN WOLF, M.D., PH.D. Executive Vice President & Chief Scientific Officer The Children’s Hospital of Philadelphia
STEPHEN SIMPSON Partner Growth Markets Life Sciences Ernst & Young, LLP
STEPHEN YODER, M.D., MBA Head, Specialty Pharmaceuticals Search & Evaluation Business Development Bristol-Myers Squibb
ROBERT SMITH Senior Vice President, Global Gene Therapy Business Rare Disease Pfizer Innovative Health Pfizer Inc. RONALD SPAIR Chief Operating Officer & Chief Financial Officer OraSure Technologies, Inc. JENNIFER STRONG Partner KPMG LLP JOHN SWARTLEY, PH.D., MBA Associate Vice Provost & Managing Director Penn Center for Innovation University of Pennsylvania PAUL TESTA Group Vice President Head of Supply Chain Shire Pharmaceuticals
THANK YOU TO OUR FORMER BOARD MEMBERS FOR YOUR CONTRIBUTIONS.
S TEP HEN ALLAN NEI L C AMP BELL GLEN GAULTO N MI C HAEL HO ERRES P HI LI P HO S BAC H DENNI S J AC KMAN BRI AN MC VEI GH J O HN SC HUELER P ERRY S TERNBERG ALAN W ES T MI C HAEL YANG
2017 MEMBER MILESTONES
DEC
Aclaris Therapeutics receives FDA approval of Eskata for seborrheic keratoses
24
Merck receives FDA approval of Steglatro for type 2 diabetes mellitus
Sunovian receives FDA approval for Lonhala Magnair Inhalation Solution to treat COPD
Lia flushable pregnancy test receives FDA approval
LifeX launches in Pittsburgh
Takeda and TiGenix announce Cx601 (darvadstrocel) received positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
Spark Therapeutics, Inc. receives FDA approval for novel gene therapy – Luxturna for rare form of inherited vision loss
25
GOVERNANCE COMMITTEES ADVOCACY GABRIEL HOLDSMAN CHAIR
IN RECOGNITION OF OUR GENEROUS SPONSORS We are deeply appreciative of the following individuals for their generous support in bringing you the 2017 Annual Report. ARMANDO ANIDO
DAVID LEDBETTER, PH.D., FACMG
STEPHEN SIMPSON
Zynerba Pharmaceuticals
Geisinger
Ernst & Young, LLP
CHRISTOPHER BURNS, PH.D.
TERRI LEE TAYLOR
ROBERT SMITH
VenatoRx Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
CHRISTOPHER CASHMAN
JEFFREY LIBSON
RONALD SPAIR
Marinus Pharmaceuticals
Cooley, LLP
OraSure Technologies, Inc.
BRUCE SHOOK
JAMES DATIN
MARC MALANDRO, PH.D., CLP, RTTP
JENNIFER STRONG
RONALD SPAIR
BioAgilytix Labs
University of Pittsburgh
KPMG LLP
BRIAN DOERNER
CHRISTIAN MANDERS
PERRY STERNBERG
Ballard Spahr LLP
Promethean LifeSciences
Shire Pharmaceuticals
MAXINE GOWEN, PH.D.
BRIAN MCVEIGH
JOHN SWARTLEY, PH.D., MBA
Trevena, Inc.
GlaxoSmithKline Pharmaceuticals
University of Pennsylvania
NINA GUSSACK
VINCENT MILANO
ERIC TEUTSCH
Pepper Hamilton LLP
Idera Pharmaceuticals, Inc.
DSM Biomedical
BRIAN HALAK, PH.D.
RITA NORTON
STEPHEN TULLMAN
Domain Associates
AmerisourceBergen Corporation
NeXeption
GABRIEL HOLDSMAN
ROBERT RADIE
NEAL WALKER, D.O.
BTG International Inc.
Egalet, Inc.
Aclaris Therapeutics
JOHN HUBBARD, PH.D., FCP
JULIAN RITCHEY
BRYAN WOLF, M.D., PH.D.
BioClinica, Inc.
Sanofi Pasteur
Children’s Hospital of Philadelphia
JOSEPH LA BARGE
KATHLEEN SHAY
STEPHEN YODER, M.D. MBA
Spark Therapeutics, Inc.
Duane Morris, LLP
Bristol-Myers Squibb
MAHMOOD LADHA
BRUCE SHOOK
AstraZeneca Pharmaceuticals
Intact Vascular, Inc.
DENNIS JACKMAN TERRI LEE TAYLOR BRIAN MCVEIGH CHRISTOPHER MOLINEAUX JULIAN RITCHEY KATHLEEN SHAY
EXECUTIVE MARC MALANDRO, PH.D., CLP CHAIR MAXINE GOWEN BRIAN HALAK JEFFR EY LIBSON VINCENT MILANO CHRISTOPHER MOLINEAUX STEPHEN TULLMAN
AUDIT VINCENT MILANO - CHAIR THOMAS HESS JEFFR EY LIBSON EDMUND LYNCH CHRISTOPHER MOLINEAUX STEPHEN SIMPSON STEPHEN TULLMAN STEPHEN WEBSTE R
26
27
6 5 0
E A S T
S U I T E
S W E D E S F O R D
R O A D
1 9 0
WAY N E ,
PA
1 9 0 8 7
WWW.LIFESCIENCESPA.ORG
